A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

NCT03173573 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis

NCT02141958 ·Status: COMPLETED ·Phase: PHASE1

Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis

NCT02767297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation

NCT03068312 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis

NCT02465450 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

NCT06237335 ·Status: RECRUITING ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients

NCT02190604 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Response to CFTR Modulators in CF Patients Under 18 Years

NCT04301856 ·Status: RECRUITING

Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients

NCT02532764 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

NCT01944735 ·Status: COMPLETED ·Phase: PHASE1

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis

NCT00757848 ·Status: COMPLETED ·Phase: PHASE2

Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis

NCT03591094 ·Status: COMPLETED ·Phase: PHASE2

A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis

NCT06478706 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease

NCT00659529 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis

NCT00570349 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF

NCT01840735 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis

NCT00506792 ·Status: COMPLETED ·Phase: PHASE2

Miglustat in Cystic Fibrosis

NCT00742092 ·Status: COMPLETED ·Phase: PHASE2

BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects

NCT02976519 ·Status: COMPLETED ·Phase: PHASE1

Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

NCT04137133 ·Status: RECRUITING ·Phase: NA

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

NCT06526923 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis

NCT00812045 ·Status: WITHDRAWN ·Phase: PHASE2

Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis

NCT02566044 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

NCT00274313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis

NCT02718495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2